drugset / Trial / NCT00037596
Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
Treatment
Summary
The primary objectives are a) to establish the maximum tolerated dose of gemtuzumab ozogamicin in combination with cytarabine and b) to assess the safety of gemtuzumab ozogamicin when given concurrently with cytarabine.
Timeline
- Start
- 2000-08
- Primary completion
- 2003-04
- Completion
- 2003-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemtuzumab Ozogamicin | Monoclonal antibody | — | — |
| Background | Cytarabine | Small molecule | — | — |